Cancer
Conditions
Brief summary
PARCOURS is a non-interventional research study evaluating dysfunctions in the continuous city-hospital journey of a patients cohort treated by oral chemotherapy (60 patients followed for 3 months). References used are the National Cancer Institute recommendations for the oral chemotherapy treated outpatients. Parameters found are : information exchanged, ambulatory and hospital monitoring in case of adverse event and adherence to treatment. The study includes also a medico-economic evaluation (hospitalization and transport spending in case of dysfunction in the patient's journey). Deviations will be analyzed.
Interventions
OTHERObservational
Evaluation of dysfunctions in the continuous city-hospital journey of a patients cohort treated by oral chemotherapy
Sponsors
MSD France
University Hospital, Caen
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient over 18 years old * Suffering from cancer (hematological malignancies, digestive tumors, thoracic tumors or cutaneous tumors) * With an oral anticancer chemotherapy initial prescription written by an oncologist or hematologist from the University Hospital of Caen, whatever the place of the drug dispensing (Community pharmacy or hospital pharmacy )
Exclusion criteria
\- Patient treated by oral anticancer chemotherapy for another pathology
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of dysfunctions | 3 months | Number of dysfunctions objectified during the 3-month follow-up period, by sub-processes of the course |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Adverse events | 3 months | number |
| Expenses related to the use of unplanned hospital care | 3 months | Expenses related to the use of unplanned hospital care during the follow-up period: number of oncologist consultations, transport spending, emergency rehospitalizations and additional examinations. |
| Satisfaction of the patient | At month 3 | RESOCAN questionnaire |
| Drug adherence | 3 months | measured by Morisky-Green's questionnaire to the patient |
| Satisfaction of the local professionals | At month 3 | RESOCAN questionnaire |
| Quality of life of patients | At month 3 | QLQC 30 |
| Satisfaction of the caregiver | At month 3 | RESOCAN questionnaire |
Countries
France
Contacts
Primary ContactValérie CHEDRU-LEGROS, PhD
Outcome results
None listed